Professor Mark Lawler spoke about the digital transformation occurring in Northern Ireland healthcare at the Economist World Cancer Series Conference in Brussels.

Published in the New England Journal of Medicine by researchers including PGJCCR's Prof Vicky Coyle, a world-first study has shown a structured exercise regime can significantly reduce the risk of colon cancer

We caught up with researchers from PGJCCR's Dunne Lab after their trip to the American Association for Cancer Research Annual Meeting

A research team from the Patrick G Johnston Centre for Cancer Research (PGJCCR) at Queen’s University Belfast is part of a new £5.5m project which aims to transform bowel cancer care.

Researchers from PGJCCR, Centre for Public Health and the School of Pharmacy deliver talks and take home prizes at all-island conference.

Members of the public invited to the opening day of the IACR Conference to help judge the most accessible research presentation.

FACILITATE is a pilot study exploring a new practical way of supporting people with advanced bowel cancer during their chemotherapy

The international prize given by the Radiation Research Society (USA) recognises exceptional accomplishments in radiation research.

The JD Williamson Prize recognises researchers delivering excellence in medical research at Queen’s University Belfast.

Postdoctoral Research fellow Dr Natalie Fisher has been awarded the prestigious Roche Researcher of the Year Award.

PGJCCR’s Professor Kevin Prise has been recognised for his work in radiobiology research

Technicians from PGJCCR have been recognised for their sustainability efforts

The BioFAIR workshop, which will be hosted by researchers from QUB and PGJCCR is part of UK-wide roadshow which aims to engage with life science research communities and will take place in QUB’s Riddel Hall.

PGJCCR’s Professor Stuart McIntosh has worked with the Lancet’s Breast Cancer Commission since its 2021 outset, co-leading its workstream on personalising and optimising breast cancer treatment and co-authoring the Commission’s accompanying report.

The All Ireland RNA Club was set up in 2023 with the aim of creating a network for researchers working in the RNA Biology field across the island of Ireland and providing opportunities for regular interactions, meetings and new collaborations.

Queen’s has become the first university on the island of Ireland and only the second in the UK to achieve the Athena Swan gold level, a prestigious higher education award, for its work improving gender equality.

Mary Mallon has been awarded the Queen’s Graduate Association Scholarship which will go towards her work in researching head and neck cancer in the Patrick G Johnston Centre for Cancer Research (PGJCCR).

International researchers and clinicians from the ORIGIN project, which seeks to develop innovative Brachytherapy technology, met in the Patrick G Johnston Centre for Cancer Research (PGJCCR) last week for the project’s final meeting.

Scientists from PGJCCR and the CRUK Scotland Institute have made a series of groundbreaking discoveries into tumour biology that may be used to deliver a more effective personalised medicine approach for patients with bowel (colorectal) cancer.

Researchers at Queen’s University Belfast and Patrick G Johnston Centre for Cancer Research (PGJCCR) have discovered a new method that could possibly improve the safety of radiotherapy for patients receiving treatment for lung cancer.

CV6 Therapeutics, based at the Patrick G. Johnston Centre for Cancer Research (PGJCCR), has received approval from the UK’s medicines regulator, the MHRA, to begin a UK-wide clinical trial for its first and novel anti-cancer drug called CV6-168.

The Patrick G Johnston Centre for Cancer Research (PGJCCR) has made history by launching Ireland’s first independent Prostate Cancer Centre of Excellence.

New all-island research led by Queen’s University Belfast and the Patrick G Johnston Centre for Cancer Research highlights the health and economic impact of the Good Friday Agreement on cancer across the island of Ireland in the last 25 years.

The donation from the Robin Menary Foundation will fund research into FLASH radiotherapy as a potential new method for the treatment of brain tumours.

PGJCCR-led research demonstrates economic benefit of precision medicine in treating cancer.

A new study, the first of its kind, highlights the extent of gender inequality and gender bias against senior female academics working in cancer research in Europe.

Researchers from Queen’s University have developed a new toolkit that harnesses the power of ‘Big Data’ for digital health with the aim of driving improvements in patient care and outcomes through data-driven innovation.

New research led by Queen’s University Belfast & the Patrick G Johnston Centre for Cancer Research has identified that the gene Spic plays a central role in regulating stem cell identity during early embryonic development.

A garden created in partnership with Myeloma UK won the People’s Choice Award at this year’s RHS Chelsea Flower Show.

Queen’s University Belfast hosted the Virtual Institute of Bioinformatics and Evolution, All-Ireland Conference 2023 (VIBE 2023) in May.

Friday 28th July saw the completion of the 2023 PGJCCR Summer Research Programme.

PGJCCR’s Dr Gerard Walls has been awarded the prestigious Fulbright Scholar Award.

Professor Dan Longley has been appointed as Director of the Patrick G Johnston Centre for Cancer Research.

Celebrating the positive impacts of the Good Friday Agreement upon cancer research and care across the island of Ireland.

Daniel tells us about taking up his new position at PGJCCR after completing his Master's here in 2022.

Taoiseach Micheál Martin visited the Patrick G Johnston Centre on Friday 8 October, to discuss all Island research collaboration.

Queen’s University Belfast has a proud tradition in Cancer Research and its translation into improving the lives of our citizens, locally, nationally and internationally.

Congratulations to Dr Karl Butterworth from The Patrick G Johnston Centre for Cancer Research has won a highly prestigious international award from the Radiation Research Society in the United States.

Researchers at Queen’s University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.

Queen's has announced they are part of a consortium that will receive a multi-million-pound investment of government/industry funding to advance the use of artificial intelligence (AI) in cancer diagnosis and precision medicine.

In an article published this month in The Lancet Oncology, a collaborative team of international researchers led by Queen’s University Belfast, outlines the imperative for maintaining public trust in the use of health data for research.

Queen’s University Belfast will hosting AIMday Big Data, AI and the One Health Agenda on Friday 19th October 2018 at Riddel Hall, Queen’s University Belfast.

Early results from an innovative new clinical trial led by researchers from Queen’s University Belfast have shown that men with prostate cancer could benefit from radical radiotherapy that delivers treatment in just five visits.

Queen’s researchers have secured a prestigious award to develop a new antibody drug for the treatment of pancreatic cancer.

QUEEN'S UNIVERSITY SCIENTISTS INVITE CITY TO UNITE FOR WORLD CANCER DAY

A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.

A £10million Centre of Excellence in Precision Medicine was launched today by Invest Northern Ireland and Queen’s University Belfast.